These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31741027)

  • 1. Urinary biomarkers profiles in patients with neurogenic detrusor overactivity according to their neurological condition.
    Richard C; Bendavid C; Hascoet J; Alimi Q; Khene ZE; Kerdraon J; Voiry C; Brochard C; Bouguen G; Siproudhis L; Manunta A; Gamé X; Peyronnet B
    World J Urol; 2020 Sep; 38(9):2261-2268. PubMed ID: 31741027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary TIMP-2 and MMP-2 are significantly associated with poor bladder compliance in adult patients with spina bifida.
    Peyronnet B; Richard C; Bendavid C; Naudet F; Hascoet J; Brochard C; Senal N; Jezequel M; Alimi Q; Khene ZE; Corlu A; Clément B; Siproudhis L; Bouguen G; Kerdraon J; Manunta A; Gamé X
    Neurourol Urodyn; 2019 Nov; 38(8):2151-2158. PubMed ID: 31486131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
    Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
    Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study.
    Konstantinidis C; Samarinas M; Tzitzika M; Kratiras Z; Panagiotakopoulos G; Giannitsas K; Athanasopoulos A
    Neurourol Urodyn; 2021 Nov; 40(8):2026-2033. PubMed ID: 34498773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
    Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
    Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines on the urological management of the adult patient with spinal dysraphism (spina bifida)].
    Manunta A; Peyronnet B; Olivari-Philiponnet C; Chartier-Kastler E; Saussine C; Phé V; Robain G; Denys P; Even A; Samson E; Grise P; Karsenty G; Hascoet J; Castel-Lacanal E; Charvier K; Guinet-Lacoste A; Chesnel C; Amarenco G; Haffner F; Haddad M; Le Normand L; Perrouin-Verbe MA; Perrouin-Verbe B; De Seze M; Ruffion A; Gamé X
    Prog Urol; 2023 Mar; 33(4):178-197. PubMed ID: 36609138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
    Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
    Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity.
    García Fadrique G; Gallego D; Ordaz D; Climent L
    Urol Int; 2020; 104(3-4):273-276. PubMed ID: 31461727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT; Chancellor MB; Kuo HC
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO).
    Frias B; Santos J; Morgado M; Sousa MM; Gray SM; McCloskey KD; Allen S; Cruz F; Cruz CD
    J Neurosci; 2015 Feb; 35(5):2146-60. PubMed ID: 25653370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain-derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity.
    Philippova ES; Bazhenov IV; Ziryanov AV; Bazarny VV
    Neurourol Urodyn; 2021 Jan; 40(1):95-101. PubMed ID: 33034916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity.
    Krhut J; Wohlfahrt P; Pudich J; Kufová E; Borovička V; Bílková K; Sýkora R; Mokriš J; Cífková R; Zachoval R; Zvara P
    Int Urol Nephrol; 2021 Jun; 53(6):1089-1095. PubMed ID: 33417146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia.
    Top T; Sekerci CA; Isbilen-Basok B; Tanidir Y; Tinay I; Isman FK; Akbal C; Simsek F; Tarcan T
    Neurourol Urodyn; 2017 Sep; 36(7):1896-1902. PubMed ID: 28090659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
    Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.
    Ferreira A; Nascimento D; Cruz CD
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
    Birkhäuser V; Liechti MD; Anderson CE; Bachmann LM; Baumann S; Baumberger M; Birder LA; Botter SM; Büeler S; Cruz CD; David G; Freund P; Friedl S; Gross O; Hund-Georgiadis M; Husmann K; Jordan X; Koschorke M; Leitner L; Luca E; Mehnert U; Möhr S; Mohammadzada F; Monastyrskaya K; Pfender N; Pohl D; Sadri H; Sartori AM; Schubert M; Sprengel K; Stalder SA; Stoyanov J; Stress C; Tatu A; Tawadros C; van der Lely S; Wöllner J; Zubler V; Curt A; Pannek J; Brinkhof MWG; Kessler TM
    BMJ Open; 2020 Aug; 10(8):e039164. PubMed ID: 32792454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patients.
    Peyronnet B; Brochard C; Jezequel M; Hascoet J; Alimi Q; Senal N; Carsin-Nicole B; Riffaud L; Le Reste PJ; Bonan I; Olivari-Philiponnet C; Siproudhis L; Kerdraon J; Game X; Manunta A
    Neurourol Urodyn; 2018 Nov; 37(8):2818-2826. PubMed ID: 30070396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
    Tapia CI; Khalaf K; Berenson K; Globe D; Chancellor M; Carr LK
    Health Qual Life Outcomes; 2013 Jan; 11():13. PubMed ID: 23369111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.